Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?
about
MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes.Exercise Metabolism in Nonobese Patients with Type 2 Diabetes Following the Acute Restoration of NormoglycaemiaHypothalamic inflammation: a double-edged sword to nutritional diseases.Body mass index and health status in diabetic and non-diabetic individuals.Lean diabetes mellitus: An emerging entity in the era of obesity.Burden and spectrum of disease in people with diabetes in Tonga.Epigenetic regulation of HGK/MAP4K4 in T cells of type 2 diabetes patients.Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki ratsPeriodontitis is associated with diabetic retinopathy in non-obese adults.Effectiveness of Minimally Invasive Hybrid Surgery for Ileal Interposition (MIHSII) for the Resolution of Type 2 Diabetes.Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San on High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats.Normal weight individuals who develop type 2 diabetes: the personal fat threshold.Prevalence and characteristics of non-obese diabetes in Japanese men and women: the Yuport Medical Checkup Center Study.Association between the number of natural teeth and diabetic retinopathy among type 2 diabetes mellitus: The Korea national health and nutrition examination survey.Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus.[Interaction between environment and genetic background in type 2 diabetes: lessons from animal models].Cardiometabolic risk factors in type 2 diabetes with high fat and low muscle mass: At baseline and in response to exercise.
P2860
Q30239799-F87CE8D0-5361-4026-9F45-16044CFEB6CEQ33787062-0925963E-43FF-40D2-A869-986FF3D32BA7Q35318592-2CEA7284-18EE-4BCC-BBC8-156E94E5CA2EQ35579353-0C34DE44-6EB0-4F33-876D-FC5ED2B306CEQ35613913-E4DA7240-6901-406B-9089-58336FCC5DAAQ35990890-2FC2AE28-0ADB-4547-9B02-C21F1FB73589Q36998143-2E3691A6-59B9-4701-934F-DCFA55D41A59Q37156557-AD28EAEE-D161-4723-A346-8774151D4791Q39055178-F822F845-7769-47B4-AAB9-9B956EFF4C50Q40856352-2461F2BE-27EB-4EF0-9935-08AE5B667C5EQ41622327-187D6495-FED6-4FFB-B0C2-B5B12FE10E2BQ41682743-C58D77A0-33DB-44D1-98FB-ABB0767C5697Q44995947-25297B1E-445E-4A40-AC7B-0D70C0C3B27AQ47111812-3FE1E98B-DF71-4FCD-BAE5-FD920E3C75C6Q51328125-D3D970AF-57E5-4E75-B24E-F69DD3E1B483Q53091487-879E888A-8D63-45A2-B057-758B4BFD1230Q53747062-10D3B4E5-FC25-4191-8C41-6DB011D60722
P2860
Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Non-obese patients with type 2 ...... treatment and (or) prevention?
@en
Non-obese patients with type 2 ...... special diabetes treatment and
@nl
type
label
Non-obese patients with type 2 ...... treatment and (or) prevention?
@en
Non-obese patients with type 2 ...... special diabetes treatment and
@nl
prefLabel
Non-obese patients with type 2 ...... treatment and (or) prevention?
@en
Non-obese patients with type 2 ...... special diabetes treatment and
@nl
P2860
P356
P1476
Non-obese patients with type 2 ...... treatment and (or) prevention?
@en
P2093
Allan Vaag
Søren S Lund
P2860
P304
P356
10.1139/H07-100
P577
2007-10-01T00:00:00Z